CY1121147T1 - Νεες συντηγμενες ενωσεις ιμιδαζοβενζοθειαζολιου - Google Patents
Νεες συντηγμενες ενωσεις ιμιδαζοβενζοθειαζολιουInfo
- Publication number
- CY1121147T1 CY1121147T1 CY20191100076T CY191100076T CY1121147T1 CY 1121147 T1 CY1121147 T1 CY 1121147T1 CY 20191100076 T CY20191100076 T CY 20191100076T CY 191100076 T CY191100076 T CY 191100076T CY 1121147 T1 CY1121147 T1 CY 1121147T1
- Authority
- CY
- Cyprus
- Prior art keywords
- compounds
- imidazovenzothiazolium
- functioned
- new
- medicament
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Abstract
Η παρούσα εφεύρεση αναφέρεται σε νέα συντηγμένα παράγωγα ιμιδαζοβενζοθειαζολίου, τα φαρμακευτικά αποδεκτά άλατα αυτών και τα ισομερή τους, τα στερεοϊσομερή, τα ατροπισομερή, τα διαμορφομερή, τα ταυτομερή, τα πολύμορφα, τα ένυδρα άλατα, τα διαλύματα και το Ν-οξείδιο. Η παρούσα εφεύρεση επίσης περιλαμβάνει τις φαρμακευτικά αποδεκτές συνθέσεις των αναφερθεισών ενώσεων και μια μέθοδο για την παρασκευή νέων ενώσεων. Η εφεύρεση αναφέρεται περαιτέρω στη χρήση των ανωτέρω αναφερθεισών ενώσεων για την παρασκευή ενός φαρμάκου προς χρήση ως φαρμακευτικά προϊόντα.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1089MU2014 | 2014-03-27 | ||
| PCT/IB2015/052124 WO2015145336A1 (en) | 2014-03-27 | 2015-03-24 | Novel fused imidazobenzothiazole compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1121147T1 true CY1121147T1 (el) | 2020-05-29 |
Family
ID=54194050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20191100076T CY1121147T1 (el) | 2014-03-27 | 2019-01-21 | Νεες συντηγμενες ενωσεις ιμιδαζοβενζοθειαζολιου |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US9908898B2 (el) |
| EP (1) | EP3122755B1 (el) |
| JP (1) | JP6480949B2 (el) |
| KR (1) | KR102339610B1 (el) |
| CN (1) | CN106414458B (el) |
| AR (1) | AR099867A1 (el) |
| AU (1) | AU2015237840B2 (el) |
| CA (1) | CA2943098C (el) |
| CY (1) | CY1121147T1 (el) |
| DK (1) | DK3122755T3 (el) |
| EA (1) | EA029745B9 (el) |
| ES (1) | ES2707099T3 (el) |
| HR (1) | HRP20190121T1 (el) |
| HU (1) | HUE042493T2 (el) |
| IL (1) | IL247955B (el) |
| LT (1) | LT3122755T (el) |
| MX (1) | MX368985B (el) |
| MY (1) | MY193041A (el) |
| PH (1) | PH12016501903B1 (el) |
| PL (1) | PL3122755T3 (el) |
| PT (1) | PT3122755T (el) |
| RS (1) | RS58324B1 (el) |
| SG (1) | SG11201607793RA (el) |
| SI (1) | SI3122755T1 (el) |
| TR (1) | TR201900735T4 (el) |
| TW (1) | TWI648282B (el) |
| UA (1) | UA121469C2 (el) |
| WO (1) | WO2015145336A1 (el) |
| ZA (1) | ZA201606598B (el) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014237340C1 (en) | 2013-03-15 | 2018-11-08 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| EA201992707A1 (ru) | 2013-11-18 | 2020-06-30 | Глобал Блад Терапьютикс, Инк. | Соединения и их применения для модуляции гемоглобина |
| TWI648282B (zh) * | 2014-03-27 | 2019-01-21 | 印度商托仁特生技有限公司 | 新熔合咪唑苯并噻唑化合物 |
| DE102016209204A1 (de) | 2016-05-27 | 2017-11-30 | Robert Bosch Gmbh | Vorrichtung zur Regelung mindestens eines Fluidstroms in einem Fahrzeug |
| KR102630959B1 (ko) * | 2016-10-31 | 2024-01-29 | 엘지디스플레이 주식회사 | 유기 화합물과 이를 이용한 발광다이오드 및 유기발광다이오드 표시장치 |
| CN106727538A (zh) * | 2017-02-20 | 2017-05-31 | 潘连香 | 一种治疗2型糖尿病的药物组合物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8724566D0 (en) * | 1987-10-20 | 1987-11-25 | Roussel Lab Ltd | Chemical compounds |
| GB8908845D0 (en) * | 1989-04-19 | 1989-06-07 | Roussel Lab Ltd | Chemical compounds |
| EP0757692A1 (en) * | 1994-04-29 | 1997-02-12 | PHARMACIA & UPJOHN COMPANY | Methanol derivatives for treatment of retroviral infections especially hiv infections |
| AU2001294515A1 (en) * | 2000-08-11 | 2002-02-25 | The Regents Of The University Of California | Use of stat-6 inhibitors as therapeutic agents |
| US7601846B2 (en) | 2001-06-26 | 2009-10-13 | The Regents Of The University Of California | Compounds having activity as inhibitors of apoptosis |
| AU2003300800A1 (en) * | 2002-11-25 | 2004-06-18 | Pharmacia Corporation | Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors |
| GB0320244D0 (en) * | 2003-05-06 | 2003-10-01 | Aventis Pharma Inc | Pyrazoles as inhibitors of tumour necrosis factor |
| US20090012079A1 (en) * | 2006-02-09 | 2009-01-08 | Russell Andrew Lewthwaite | Triazolopyridine Compounds |
| TWI648282B (zh) * | 2014-03-27 | 2019-01-21 | 印度商托仁特生技有限公司 | 新熔合咪唑苯并噻唑化合物 |
-
2015
- 2015-03-16 TW TW104108329A patent/TWI648282B/zh active
- 2015-03-24 ES ES15717242T patent/ES2707099T3/es active Active
- 2015-03-24 CA CA2943098A patent/CA2943098C/en active Active
- 2015-03-24 EP EP15717242.0A patent/EP3122755B1/en active Active
- 2015-03-24 LT LTEP15717242.0T patent/LT3122755T/lt unknown
- 2015-03-24 JP JP2016559356A patent/JP6480949B2/ja not_active Expired - Fee Related
- 2015-03-24 US US15/128,886 patent/US9908898B2/en active Active
- 2015-03-24 PT PT15717242T patent/PT3122755T/pt unknown
- 2015-03-24 MX MX2016012535A patent/MX368985B/es active IP Right Grant
- 2015-03-24 RS RS20190084A patent/RS58324B1/sr unknown
- 2015-03-24 HU HUE15717242A patent/HUE042493T2/hu unknown
- 2015-03-24 SG SG11201607793RA patent/SG11201607793RA/en unknown
- 2015-03-24 UA UAA201610628A patent/UA121469C2/uk unknown
- 2015-03-24 SI SI201530555T patent/SI3122755T1/sl unknown
- 2015-03-24 AU AU2015237840A patent/AU2015237840B2/en not_active Ceased
- 2015-03-24 TR TR2019/00735T patent/TR201900735T4/tr unknown
- 2015-03-24 WO PCT/IB2015/052124 patent/WO2015145336A1/en active Application Filing
- 2015-03-24 EA EA201691920A patent/EA029745B9/ru not_active IP Right Cessation
- 2015-03-24 PL PL15717242T patent/PL3122755T3/pl unknown
- 2015-03-24 DK DK15717242.0T patent/DK3122755T3/en active
- 2015-03-24 CN CN201580024068.6A patent/CN106414458B/zh not_active Expired - Fee Related
- 2015-03-24 MY MYPI2016703533A patent/MY193041A/en unknown
- 2015-03-24 KR KR1020167029134A patent/KR102339610B1/ko active IP Right Grant
- 2015-03-27 AR ARP150100915A patent/AR099867A1/es not_active Application Discontinuation
-
2016
- 2016-09-21 IL IL247955A patent/IL247955B/en active IP Right Grant
- 2016-09-23 ZA ZA2016/06598A patent/ZA201606598B/en unknown
- 2016-09-27 PH PH12016501903A patent/PH12016501903B1/en unknown
-
2018
- 2018-01-03 US US15/861,399 patent/US10227361B2/en active Active
-
2019
- 2019-01-21 HR HRP20190121TT patent/HRP20190121T1/hr unknown
- 2019-01-21 CY CY20191100076T patent/CY1121147T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1121147T1 (el) | Νεες συντηγμενες ενωσεις ιμιδαζοβενζοθειαζολιου | |
| PH12018500591A1 (en) | Heterocyclic compounds and uses thereof | |
| EA201791256A1 (ru) | Производные хиназолина, применяемые для лечения вич | |
| EA201691302A1 (ru) | Новые гетероциклические соединения | |
| CO2018000589A2 (es) | Oxiesteroles y composiciones farmacéuticas que los contienen | |
| EA201790389A1 (ru) | Пирролопиримидиновые соединения, используемые в качестве агониста tlr7 | |
| EA201791304A1 (ru) | Производные изохинолина для лечения вич | |
| UY35663A (es) | Derivados de piperidinil-indol como inhibidores del factor de complemento b y usos de los mismos | |
| TW201613872A (en) | IRAK4 inhibiting agents | |
| CU20160192A7 (es) | Derivados de indano e indolina útiles como activadores de la guanilato ciclasa soluble | |
| EA201790395A1 (ru) | Производные аминотриазина, подходящие для применения в качестве соединений-ингибиторов tank-связывающей киназы | |
| TW201613567A (en) | Use of gabaa receptor reinforcing agent in preparation of sedative and anesthetic medicament | |
| DOP2017000034A (es) | Compuestos de imidazopiridazina | |
| CY1124251T1 (el) | Παραγωγα καρβοξαμιδιου | |
| EA201791600A1 (ru) | Производные гидроксиалкилпиперазина в качестве модуляторов cxcr3 рецептора | |
| UY36123A (es) | Derivados de carboxamida | |
| MA40250A (fr) | Dérivés de quinolizinone utilisés comme inhibiteurs de pi3k | |
| CY1119710T1 (el) | Συντηγμενες θειαζολο- και οξαζολο-πυριμιδινονες | |
| MX2017009292A (es) | Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3. | |
| EA201792234A1 (ru) | Новые соединения пиридиния | |
| ECSP19013196A (es) | Derivado de triazolopirazinona útil como un inhibidor de pde1 humana | |
| PH12018502246A1 (en) | Substituted fused pyrimidinone compounds | |
| EA201791396A1 (ru) | ПРОИЗВОДНЫЕ ИМИДАЗОПИРИДАЗИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3Kβ | |
| EA201791397A1 (ru) | СВЯЗАННЫЕ С ГЕТЕРОЦИКЛИЛАМИ ПРОИЗВОДНЫЕ ИМИДАЗОПИРИДАЗИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3Kβ | |
| MX2018015990A (es) | Compuestos terapeuticos. |